Personal Information
Organization / Workplace
Bangalore, Karnataka India
Website
www.biocon.com
About
DELIVERING AFFORDABLE INNOVATION
Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, we offer novel therapies on a platform of affordable innovation.
We believe our strategic licensing partnerships will rapidly provide us wider global access and greater market penetration. More significantly, they will enable us to deliver breakthrough therapeutics to millions of patients the world over.
Tags
biocon
biocon careers
biotech jobs
biocon walk-in
biocon interviews
careers
hr
biocon jobs
biotechnology
walk-in interview
bangalore
jobs
biotech careers
diabetes
hyderabad
interview
biocon investor presentation
insulin
india
interviews
healthcare
annual results
hiring
biotech
recruitment
biosimilars
q4 results
biopharmaceutical
buy
axis
capital
letter
abdul kalam
visionary
apj abdul kalam
inspiration
pollution
bio waste
pharma careers
hyderabad jobs
human resources
biocon financial results
fy2014 results
biocon limited
walkin
kiran mazumdar-shaw
syngene
media presentation
press release
fy12
q3
pharmaceutical
bengaluru
insulins production
job
recruiting
job search
career
kiran mazumdar shaw
annual general meeting
speech
diabetes patients
insulin glargine
fujifilm pharma
basalog one’
regulatory approval
japan
q3fy16
report
#financial
#revenues
#results
#profit
#q3fy16
price
target
novel
hepatitis
therapy
walk-in
margao
goa
novartis
uae
neobiocon
winning with diabetes
walkin interviews
job application
candidates
biocon hr
make in india
amitabh kant
biocon bangalore
chennai jobs
walk in interviews
conferences
biocon conferences
pharma conference
biocon microbiology
bangalore conferences
pharmaceutical microbiology
pharma
microbiology
kspcb
pollution control
karnataka
waste management
environment
biodegradable
cell mass disposal
goa jobs
andhra pradesh jobs
vizag
walk-in interviews
mysore
job interview
madhya pradesh biotech
stock markets
investments
investors
biocon investors
american medical association
us fda
ama
drugs
biocon q4 & fy2014
biocon media presentation
biocon results presentation
biocon quarterly results
biocon stocks
quarter results
financial results
biocon foundation and ottet join hands to strength
canara bank
psoriasis faqs
world polio day
stop using tobacco
other heart diseases
what are the signs of stroke and what should you d
preventing heart attacks and strokes
understanding heart attacks and strokes - by world
biocon's eureka moment - mint asia
biocon investors presentation july 2013
biocon q1fy14
post earning conference call
transcript
conference call
enabling entrepreneurship for inclusive economic d
biocon investor presentation jan 2013
biocon press release on q39m fy13 results
trinity college
dublin
an oral insulin drug candidate
biocon announces that it has entered into an optio
h1fy13
h1fy13 results
ge capital
malaysia
mou
manipal education
2012
biocon agm 2012 presentation july 26
abbott
results presentation
april 2012
investor presentation
q4
9m
h1
september2011
q1
fy2012
jp morgan
innovative science affordable medicine
health conference january 2012
insulin storage technique
slide
presentation
investor
diabetology
insugen
bio pharma
biotechonology
See more
Presentations
(26)
See all
Documents
(34)
See all
Presentations
(26)
See all
Documents
(34)
See all
Personal Information
Organization / Workplace
Bangalore, Karnataka India
Website
www.biocon.com
About
DELIVERING AFFORDABLE INNOVATION
Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, we offer novel therapies on a platform of affordable innovation.
We believe our strategic licensing partnerships will rapidly provide us wider global access and greater market penetration. More significantly, they will enable us to deliver breakthrough therapeutics to millions of patients the world over.
Tags
biocon
biocon careers
biotech jobs
biocon walk-in
biocon interviews
careers
hr
biocon jobs
biotechnology
walk-in interview
bangalore
jobs
biotech careers
diabetes
hyderabad
interview
biocon investor presentation
insulin
india
interviews
healthcare
annual results
hiring
biotech
recruitment
biosimilars
q4 results
biopharmaceutical
buy
axis
capital
letter
abdul kalam
visionary
apj abdul kalam
inspiration
pollution
bio waste
pharma careers
hyderabad jobs
human resources
biocon financial results
fy2014 results
biocon limited
walkin
kiran mazumdar-shaw
syngene
media presentation
press release
fy12
q3
pharmaceutical
bengaluru
insulins production
job
recruiting
job search
career
kiran mazumdar shaw
annual general meeting
speech
diabetes patients
insulin glargine
fujifilm pharma
basalog one’
regulatory approval
japan
q3fy16
report
#financial
#revenues
#results
#profit
#q3fy16
price
target
novel
hepatitis
therapy
walk-in
margao
goa
novartis
uae
neobiocon
winning with diabetes
walkin interviews
job application
candidates
biocon hr
make in india
amitabh kant
biocon bangalore
chennai jobs
walk in interviews
conferences
biocon conferences
pharma conference
biocon microbiology
bangalore conferences
pharmaceutical microbiology
pharma
microbiology
kspcb
pollution control
karnataka
waste management
environment
biodegradable
cell mass disposal
goa jobs
andhra pradesh jobs
vizag
walk-in interviews
mysore
job interview
madhya pradesh biotech
stock markets
investments
investors
biocon investors
american medical association
us fda
ama
drugs
biocon q4 & fy2014
biocon media presentation
biocon results presentation
biocon quarterly results
biocon stocks
quarter results
financial results
biocon foundation and ottet join hands to strength
canara bank
psoriasis faqs
world polio day
stop using tobacco
other heart diseases
what are the signs of stroke and what should you d
preventing heart attacks and strokes
understanding heart attacks and strokes - by world
biocon's eureka moment - mint asia
biocon investors presentation july 2013
biocon q1fy14
post earning conference call
transcript
conference call
enabling entrepreneurship for inclusive economic d
biocon investor presentation jan 2013
biocon press release on q39m fy13 results
trinity college
dublin
an oral insulin drug candidate
biocon announces that it has entered into an optio
h1fy13
h1fy13 results
ge capital
malaysia
mou
manipal education
2012
biocon agm 2012 presentation july 26
abbott
results presentation
april 2012
investor presentation
q4
9m
h1
september2011
q1
fy2012
jp morgan
innovative science affordable medicine
health conference january 2012
insulin storage technique
slide
presentation
investor
diabetology
insugen
bio pharma
biotechonology
See more